Enlightify Inc. (ENFY): Nasdaq/NYSE listing notice — Enlightify (ENFY) notified NYSE of intent to cure $1.00 minimum price deficiency; 6-month cure period.

Enlightify Inc.

NYSE notified Enlightify on Aug 27, 2025 that average closing price fell below $1.00 over 30 days.
Company submitted letter on Sept 9, 2025 of intent to cure; six-month window (subject to extension) to regain compliance.
Common stock continues trading on NYSE during cure period; business operations and SEC reporting unaffected.
No default triggered under material debt or other agreements.

item 3.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Enlightify Inc. received a nyse deficiency notice notice regarding minimum bid price (rules 802.01C).

Exchange: nyse
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 802.01C

Exact text from the filing

August 27, 2025, the New York Stock Exchange (“NYSE”) notified Enlightify Inc. (the “Company”) that the 30-trading-day average closing price of the Company’s common stock had fallen below $1.00 per share, the minimum average share price required for continued listing of the Company’s common stock on the NYSE under Rule 802.01C of the NYSE Listed Company Manual. Pursuant to applicable NYSE rules, the Company has responded to the NYSE by letter of September 9, 2025 informing the NYSE of its intent to cure the share price deficiency for the purpose of returning to compliance with the continued li

View on SEC.gov

20 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

Enlightify Inc. filing history →

Source: SEC EDGAR

accession 0001213900-25-086597

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.